Akums Drugs & Pharmaceuticals Ltd. has received a certificate confirming compliance with the SEBI (Depositories and Participants) Regulations for the quarter ended December 31, 2025. The certificate was received from MUFG Intime India Private Limited, the Registrar & Share Transfer Agent (RTA), ensuring adherence to regulatory requirements for depositories and participants.
Regulatory Compliance Confirmation
Akums Drugs & Pharmaceuticals Ltd. has received confirmation of its compliance with regulatory standards concerning depositories and participants. The certificate, issued by MUFG Intime India Private Limited, validates the company’s adherence to the SEBI regulations for the quarter ending December 31, 2025. This announcement was made on January 7, 2026.
Details of Compliance
The certificate confirms that securities received for dematerialization during Q3 (Oct-Dec) 2025 were processed according to regulations. MUFG Intime India Private Limited, the company’s Registrar & Share Transfer Agent (RTA), confirmed the acceptance or rejection of these securities to the depositories. The certificate ensures that all security certificates received for dematerialization have been duly verified, mutilated, and cancelled.
Source: BSE
